SiliconANGLEValley
OpenAI acquires Orchestra Bio to bring AI agents into drug development
OpenAI Group PBC revealed today that it has acquired drug development software startup Orchestra Bio Inc.
Read at SiliconANGLE ↗Related

EuropeDaytona hits $1B valuation with $60M Series B for AI agent cloud Tech.eu

AsiaAutonomous delivery vehicle maker Neolix raises nearly $400 million in Series E funding TechNode

VoicesNew paper: Emerging trends in AI agent evaluation AI Snake Oil

AsiaHunar Raises ₹40 Cr To Scale Agentic AI For Frontline Hiring Inc42

LabsBuilding trust in AI agents: A production-ready evaluation framework with Amazon Bedrock AgentCore AWS Machine Learning
